August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS32
Academic Journal
Presents an abstract of the research manuscript `Meta-analysis of hyperhomocyst(e)inemia as a risk factor for venous thromboembolic disease,' by Joel G. Ray from the McMaster University.


Related Articles

  • Mild glucose elevations heighten risk of thromboembolic stroke.  // Geriatrics;Sep94, Vol. 49 Issue 9, p57 

    Reports on Honolulu Heart Program stating that diabetic men with mildly elevated glucose levels and asymptomatic hyperglycemia are at increased risk for thromboembolic stroke. Ranges of age of Japanese-American men studied; Classification of subjects; Chance of older men in the...

  • Current Clinical Concepts in Perioperative Anticoagulation. HEWITT, ROBERT L.; CHUN, KENDRA L.; FLINT, LEWIS M. // American Surgeon;Mar1999, Vol. 65 Issue 3, p270 

    Proposes ways in managing patients with significant risks for thromboembolism. Use of intravenous heparin; Potential complications of heparin; Patient monitoring approach.

  • Primary Venous Thromboembolism and Cancer Screening. B├╝ller, Harry; ten Cate, Jan Wouter // New England Journal of Medicine;04/23/98, Vol. 338 Issue 17, p1221 

    Editorial. Comments on studies made to determine any association between primary venous thromboembolism and cancer; Reason for differences in results; Reference to the study by Sorensen et al in this issue; The suggestion there is insufficient evidence to support extensive cancer screening of...

  • FDA Actions.  // Critical Care Alert;March2008 Pharmacology Watch, p2 

    The article reports that the Food and Drug Administration has increased its warning on Ortho Evra, a contraceptive patch, due to a risk of venous thromboembolism.

  • Oral contraceptives, HRT and risk of thromboembolism. Apgar, Barbara // American Family Physician;2/15/1998, Vol. 57 Issue 4, p849 

    Presents a study by J.D. Douketis on the evaluation of the risk associated with thromboembolism with the use of contraceptives and hormone replacement therapy, originally from the journal `Archives of Internal Medicine,' volume 157, 1997 issue. Details on the study; Examination of the study;...

  • Internal medicine (clinical vignettes) & (research).  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS45 

    Presents an abstract of the research manuscript `Risk factors for venous thromboembolism in 202 women carriers of factor V Leiden mutation and oral contraceptive users,' by S. Desmarais, J. Conard et al.

  • Risk of prophylaxis for venous thromboembolism in hospital patients. Lowe, G.D.O.; Greer, I.A.; Dewar, E.P.; Evans, M.J.; Forbes, C.D.; Mollan, R.A.B.; Scurr, J.H.; de Swiet, M. // BMJ: British Medical Journal (International Edition);9/5/92, Vol. 305 Issue 6853, p567 

    Incidence of venous thromboembolism of hospital patients in Great Britain. Risk factors of thromboembolism; Efficacy of prophylactic method; Recommendations for prophylaxis in surgical and medical patients.

  • News & views. Hinchey, Kevin T. // Cortlandt Forum;10/25/97, Vol. 10 Issue 10, p35 

    Presents an abstract and comment on the study `Risk for Thromboembolism in Patients With Atrial Fibrillation Converted to Sinus Rhythm Within 48 Hours,' by M.J. Weigner, T.A. Caulfield et al and published in a 1997 issue of the `Annals of Internal Medicine.'

  • Third-generation oral contraceptives are safe for most women.  // Modern Medicine;Sep97, Vol. 65 Issue 9, p58 

    Presents an abstract of the article `Third-generation Oral Contraceptives and Thromboembolism Risk,' by A.N. Poindexter published in the June 1997 issue of `Obstetrics and Gynecology' journal.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics